ПРИМЕНЕНИЕ ДРОНЕДАРОНА ИЛИ ЕГО ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМОЙ СОЛИ ДЛЯ ПОЛУЧЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА ДЛЯ ВВЕДЕНИЯ ВСКОРЕ ПОСЛЕ ПРЕКРАЩЕНИЯ ВВЕДЕНИЯ АМИОДАРОНА

• 收藏
• 分享

专利权人:

САНОФИ (FR)

发明人:

ГОДЭН Кристоф (FR),МЕРИУА Исен (FR),РАДЗИК Давиде (FR)

申请号：

RU2012143550/15

公开号：

RU2012143550A

申请日:

2011.03.11

申请国别(地区):

RU

年份:

2014

代理人:

摘要：

CLAIMS 1. Use of dronedarone or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for use in the prevention and / or treatment of patients with atrial fibrillation (AF) or atrial flutter (TA), soon after cessation of treatment prior amiodaronom.2. Use according to claim 1 for the preparation of a medicament for use in the prevention and / or treatment of patients with atrial fibrillation (AF) and / or atrial flutter (TA) for a period of at least five half-life periods after said prekrascheniya.3 amiodarone. Use according to claim 1 for the preparation of a medicament for use in the prevention and / or treatment of patients with atrial fibrillation (AF) and / or atrial flutter (TA), shortly, within four weeks after said prekrascheniya.4. Use according to claim 1 for the preparation of a medicament for use in the prevention and / or treatment of patients with atrial fibrillation (AF) and / or atrial flutter (TA) for two weeks shortly after said prekrascheniya.5. Use according to claim 1 for the preparation of a medicament for use in the prevention and / or treatment of patients with atrial fibrillation (AF) or atrial flutter (TA) within two days after said prekrascheniya.6. Use according to claim 1 for the preparation of a medicament for use in the prevention and / or treatment of patients with atrial fibrillation (AF) and / or atrial flutter (TA) within one day after said prekrascheniya.7. Use according to claim 1 for the preparation of a medicament for use in the prevention and / or treatment of patients1. Применение дронедарона или его фармацевтически приемлемой соли для получения лекарственного средства для применения для предупреждения и/или лечения пациентов с фибрилляцией предсердий (ФП) или трепетанием предсердий (ТП), вскоре после прекращения введения предшествующего лечения амиодароном.2. Применение по п.1 для получения лекарственного средства для применения для предупреждения и/или лечения пациентов с фибрилляцией предсердий (ФП

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/